SCHEMBL14083930

SCHEMBL14083930

COc1cccc(NC(=O)c2ccc(-c3ncccc3Cl)cn2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM4 Q14833 1/20 0.62
▸ MEN1 O00255 5/20 0.57
▸ KMT2A Q03164 5/20 0.57
▸ MAPT P10636 4/20 0.56
▸ KDM4E B2RXH2 2/20 0.56
▸ HTT P42858 1/20 0.56
▸ SMN1; SMN2 Q16637 4/20 0.54
▸ TSHR P16473 1/20 0.54
▸ LMNA P02545 2/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ CYP2D6 P10635 1/20 0.53
▸ CYP2C9 P11712 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ NPSR1 Q6W5P4 1/20 0.53
▸ ALDH1A1 P00352 2/20 0.52
▸ HPGD P15428 1/20 0.52
▸ HIF1A Q16665 1/20 0.52
▸ IRAK4 Q9NWZ3 1/20 0.52
▸ THRB P10828 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14084028 0.90 GRM4 (0.50) GRM4MEN1KMT2AMAPTKDM4E
SCHEMBL14084034 0.89 GRM4 (0.48) GRM4MEN1KMT2AMAPTKDM4E
SCHEMBL14083465 0.88 TRPV1 (0.63) GRM4MEN1KMT2AMAPTKDM4E
SCHEMBL14083905 0.88 RAB9A (0.60) MEN1KMT2AMAPTKDM4ESMN1; SMN2
SCHEMBL14084016 0.86 P2RX1 (0.51) GRM4MAPTHTTTSHRALDH1A1
SCHEMBL14083913 0.85 GRM4 (0.60) GRM4MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL14083936 0.85 GRM4 (0.66) GRM4MEN1KMT2AMAPTKDM4E
SCHEMBL14083998 0.85 KDM4E (0.62) GRM4MAPTKDM4ESMN1; SMN2LMNA
SCHEMBL14083942 0.84 TRPV1 (0.57) MAPTKDM4ENPC1TRPV1
SCHEMBL14083963 0.83 POLB (0.53) MEN1KMT2AMAPTKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 GRM4 362/4885MEN1 4218/4885KMT2A 4272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback